Published in J Clin Immunol on September 08, 2012
Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? Viruses (2015) 1.07
Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections. J Infect Dis (2014) 0.83
Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection. Front Immunol (2013) 0.82
Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. J Transl Med (2014) 0.76
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 18.53
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 17.42
A new classification for HIV-1. Nature (1998) 5.30
Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood (1989) 4.76
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature (2000) 3.81
Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood (2011) 2.74
Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol (2007) 2.51
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol (2007) 2.41
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A (2002) 2.31
The three human monocyte subsets: implications for health and disease. Immunol Res (2012) 2.08
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One (2010) 1.94
CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol (1998) 1.85
Differential expression of cytokines in human blood monocyte subpopulations. Blood (1992) 1.84
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS (1998) 1.70
CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients. J Acquir Immune Defic Syndr (2009) 1.29
IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol (1998) 1.28
CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands. J Immunol (2006) 1.14
HIV-1 in peripheral blood monocytes: an underrated viral source. J Antimicrob Chemother (2002) 1.09
Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS One (2011) 1.09
Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol (2007) 1.07
Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. J Leukoc Biol (2012) 1.03
CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis. Eur J Immunol (2011) 1.02
Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals. Int Immunol (2006) 0.95
Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings. Clin Immunol (2007) 0.84
Dichotomous effects of C-C chemokines in HIV-1 pathogenesis. Immunol Lett (2007) 0.82
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet (2007) 4.76
The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood (2007) 4.14
C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest (2002) 2.11
Depletion of functionally active CD20+ T cells by rituximab treatment. Arthritis Rheum (2009) 1.87
Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol (2010) 1.61
Prevalence of antibodies against alpha-fodrin in Sjögren's syndrome: comparison of 2 sets of classification criteria. J Rheumatol (2003) 1.57
Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum (2003) 1.57
Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J Clin Invest (2006) 1.51
Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest (2002) 1.50
The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum (2005) 1.45
Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation. J Immunol (2005) 1.45
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. AIDS (2003) 1.43
Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype. Hepatology (2006) 1.41
Oculocutaneous albinism accompanied by minor morphologic stigmata and reduced number and function of NK cells. A new variant of NK cell defect? Eur J Pediatr (2008) 1.37
Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. Arthritis Res Ther (2009) 1.29
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis (2010) 1.25
STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation. Blood (2008) 1.23
Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum (2005) 1.23
Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem (2002) 1.15
HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells. J Virol (2009) 1.11
Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome. Rheumatology (Oxford) (2009) 1.09
Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J Leukoc Biol (2006) 1.06
Adverse events of desirable gain in immunocompetence: the Immune Restoration Inflammatory Syndromes. Autoimmun Rev (2004) 1.05
NKG2C deletion is a risk factor of HIV infection. AIDS Res Hum Retroviruses (2012) 1.02
CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis. Eur J Immunol (2011) 1.02
Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants. J Immunol (2008) 1.01
Gαi2 is the essential Gαi protein in immune complex-induced lung disease. J Immunol (2012) 1.01
Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. J Immunol (2012) 0.99
Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population. Eur J Immunol (2010) 0.99
Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity. Immunology (2003) 0.98
Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood (2010) 0.97
Phosphoinositide 3-kinases gamma and delta, linkers of coordinate C5a receptor-Fcgamma receptor activation and immune complex-induced inflammation. J Biol Chem (2008) 0.96
Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest (2002) 0.96
Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors. Antimicrob Agents Chemother (2009) 0.95
Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia. J Acquir Immune Defic Syndr (2005) 0.95
Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals. Int Immunol (2006) 0.95
Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir Ther (2007) 0.94
Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur J Immunol (2009) 0.94
New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. Immunobiology (2007) 0.93
Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity. J Immunol (2011) 0.92
Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion. J Leukoc Biol (2013) 0.91
Characterization of the murine IgG Fc receptor III and IIB gene promoters: a single two-nucleotide difference determines their inverse responsiveness to C5a. J Biol Chem (2007) 0.91
HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis. J Clin Virol (2011) 0.90
Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease. AIDS (2003) 0.89
The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens. Eur J Immunol (2010) 0.89
Flares in patients with systemic lupus erythematosus are associated with daily psychological stress. Psychother Psychosom (2003) 0.89
Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16+ natural killer cells in HIV infection. AIDS (2010) 0.88
Kinetics of the early recruitment of leukocyte subsets at the sites of tumor cells in the lungs: natural killer (NK) cells rapidly attract monocytes but not lymphocytes in the surveillance of micrometastasis. Int J Cancer (2002) 0.87
Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans. PLoS One (2013) 0.86
CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26. Cancer Immunol Immunother (2003) 0.86
Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings. Rheumatology (Oxford) (2010) 0.86
Oxidative stress decreases G protein-coupled receptor kinase 2 in lymphocytes via a calpain-dependent mechanism. Mol Pharmacol (2002) 0.85
Intravenous immunoglobulin (IVIG)-mediated neutralisation of C5a: a direct mechanism of IVIG in the maintenance of a high Fc gammaRIIB to Fc gammaRIII expression ratio on macrophages. Br J Haematol (2006) 0.85
Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion. Antimicrob Agents Chemother (2008) 0.85
Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment. J Hepatol (2009) 0.85
Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay. Immunol Lett (2009) 0.85
Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings. Clin Immunol (2007) 0.84
Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosus. J Clin Immunol (2007) 0.84
Vγ2Vδ2 T cells are skewed toward a terminal differentiation phenotype in untreated HIV infection. J Infect Dis (2013) 0.84
Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients. J Clin Immunol (2004) 0.84
Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide. Sci Transl Med (2010) 0.83
Targeting of platelet integrin alphaIIbbeta3 determines systemic reaction and bleeding in murine thrombocytopenia regulated by activating and inhibitory FcgammaR. Int Immunol (2003) 0.83
Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load. PLoS One (2012) 0.82
Mechanism of host cell MAPK/ERK-2 incorporation into lentivirus particles: characterization of the interaction between MAPK/ERK-2 and proline-rich-domain containing capsid region of structural protein Gag. J Mol Biol (2011) 0.82
New insights into the pathophysiology and in vivo function of IgG Fc receptors through gene deletion studies. Arch Immunol Ther Exp (Warsz) (2003) 0.82
Combined effect of C-reactive protein and stavudine on adipogenesis. Antivir Ther (2009) 0.82
Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection. Front Immunol (2013) 0.82
Kinetic analysis by real-time PCR of hepatitis C virus (HCV)-specific T cells in peripheral blood and liver after challenge with HCV. J Virol (2008) 0.82
Dichotomous effects of C-C chemokines in HIV-1 pathogenesis. Immunol Lett (2007) 0.82
Antibodies against alpha-fodrin in Sjögren's syndrome. Autoimmun Rev (2003) 0.82
GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients. J Med Virol (2008) 0.82
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection. PLoS One (2012) 0.81
Mutual interference of HIV and natural killer cell-mediated immune response. Mol Immunol (2005) 0.81
Human CD8(+) T cells and NK cells express and secrete S100B upon stimulation. Brain Behav Immun (2011) 0.81
Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients. Viral Immunol (2012) 0.81
Regulation of killer immunoglobulin-like receptors in systemic lupus erythematosus. J Rheumatol (2006) 0.80
Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients. AIDS (2002) 0.80
Immunoglobulin-like transcripts as risk genes for autoimmunity. Ann N Y Acad Sci (2007) 0.80
Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels. Brain Behav Immun (2012) 0.79
Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV/AIDS Rep (2004) 0.79
Association of an NKG2D gene variant with systemic lupus erythematosus in two populations. Hum Immunol (2010) 0.79
Pathogenesis of the HAART-associated metabolic syndrome. Adv Cardiol (2003) 0.78
In vivo monitoring of natural killer cell-dependent clearance of lung metastasis using dynamic positron emission tomography. In Vivo (2012) 0.78
Thymidine analogues suppress autophagy and adipogenesis in cultured adipocytes. Antimicrob Agents Chemother (2012) 0.78
Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria. Transpl Int (2003) 0.78
Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis. Cell Mol Life Sci (2015) 0.78
Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. J Acquir Immune Defic Syndr (2016) 0.78
Higher risk of cytomegalovirus reactivation in human immunodeficiency virus-1-infected patients homozygous for MICA5.1. Hum Immunol (2009) 0.77